PT  - JOURNAL ARTICLE
AU  - Kalaitzidis, Demetrios
AU  - Ghonime, Mohammed
AU  - Chain, Robert
AU  - Jaishankar, Nivedita
AU  - Settipane, Davis
AU  - Padalia, Zinkal
AU  - Zakas, Lauren
AU  - Kuppuraju, Meghna
AU  - Tetteh, Paul
AU  - Dequeant, Mary-Lee
AU  - Karnik, Sushant
AU  - Massilamany, Chandirasegaran
AU  - McEwan, Brigid
AU  - Dar, Henia
AU  - Allen, Melanie
AU  - Serwer, Laura
AU  - Nguyen, Thao
AU  - Butler-Gauthier, Melanie
AU  - Sripakdeevong, Parin
AU  - Nagar, Shashwat
AU  - Tang, Yin
AU  - Flanagan, Nicole
AU  - Huang, Elaine
AU  - Phuyal, Shashwant
AU  - Dunn, Andrew
AU  - Koch, Elizabeth
AU  - Sula, Erisa
AU  - Waldman, Jacob
AU  - Zhang, Maria Lei
AU  - Loaiza, Cristian
AU  - Thorstensen, Erin
AU  - Steiger, Keith
AU  - Schum, Katie
AU  - Urbaez, Kayla
AU  - Ma, Anna
AU  - Weaver, Annie Yang
AU  - Finch, Christopher
AU  - Cohen, Sarah
AU  - Morrow, PK
AU  - Benton, Mark
AU  - Terrett, Jonathan
TI  - 274 Development of CTX112 a next generation allogeneic multiplexed CRISPR-edited CART cell therapy with disruptions of the TGFBR2 and Regnase-1 genes for improved manufacturing and potency
AID  - 10.1136/jitc-2023-SITC2023.0274
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A314--A314
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A314.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A314.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.